Technology
T-cell Therapy Platform technology of Eutilex's T-cell Therapy 4-1BB based isolation and expansion of tumor antigen specific CD8+ T cells
Antibody Therapy
Costim(Co Stimulatory) platform technology
Eutilex has possessed antibody pipelines for many different T cell receptors knowledge base Costim (Co Stimulatory) platform technology,
and is also developing a number of unique antibodies.
The strength of Eutilex Costim platform technology is its response to drastic changes in market,
society and technology environment with flexible and speedy manner.
CAR-T Cell Therapy
